BE2014C050I2 - Circovirus sequences associated with piglet weight loss disease (PWD) - Google Patents

Circovirus sequences associated with piglet weight loss disease (PWD)

Info

Publication number
BE2014C050I2
BE2014C050I2 BE2014C050C BE2014C050C BE2014C050I2 BE 2014C050 I2 BE2014C050 I2 BE 2014C050I2 BE 2014C050 C BE2014C050 C BE 2014C050C BE 2014C050 C BE2014C050 C BE 2014C050C BE 2014C050 I2 BE2014C050 I2 BE 2014C050I2
Authority
BE
Belgium
Prior art keywords
pwd
circovirus
polypeptides
vectors
weight loss
Prior art date
Application number
BE2014C050C
Other languages
English (en)
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9514225&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE2014C050(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of BE2014C050I2 publication Critical patent/BE2014C050I2/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10061—Methods of inactivation or attenuation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
BE2014C050C 1997-12-05 2014-08-14 Circovirus sequences associated with piglet weight loss disease (PWD) BE2014C050I2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9715396A FR2772047B1 (fr) 1997-12-05 1997-12-05 Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
PCT/FR1998/002634 WO1999029871A2 (fr) 1997-12-05 1998-12-04 Sequences de circovirus associe a la maladie de l'amaigrissement du porcelet (map)

Publications (1)

Publication Number Publication Date
BE2014C050I2 true BE2014C050I2 (en) 2018-07-04

Family

ID=9514225

Family Applications (2)

Application Number Title Priority Date Filing Date
BE2014C049C BE2014C049I2 (en) 1997-12-05 2014-08-14 Circovirus sequences associated with piglet weight loss disease (PWD)
BE2014C050C BE2014C050I2 (en) 1997-12-05 2014-08-14 Circovirus sequences associated with piglet weight loss disease (PWD)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BE2014C049C BE2014C049I2 (en) 1997-12-05 2014-08-14 Circovirus sequences associated with piglet weight loss disease (PWD)

Country Status (15)

Country Link
US (43) US6703023B1 (fr)
EP (6) EP1992696B1 (fr)
AT (1) ATE412664T1 (fr)
AU (1) AU1491699A (fr)
BE (2) BE2014C049I2 (fr)
CY (6) CY1115405T1 (fr)
DE (1) DE69840174D1 (fr)
DK (5) DK2000535T3 (fr)
ES (5) ES2548146T3 (fr)
FR (3) FR2772047B1 (fr)
HK (5) HK1125676A1 (fr)
LU (2) LU92524I2 (fr)
NL (2) NL300686I2 (fr)
PT (5) PT1036180E (fr)
WO (1) WO1999029871A2 (fr)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002302120B2 (en) * 1997-10-03 2006-01-19 Merial Porcine circoviruses, vaccines and diagnostic reagents
US7192594B2 (en) 1997-10-03 2007-03-20 Merial Limited Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
US6517843B1 (en) * 1999-08-31 2003-02-11 Merial Reduction of porcine circovirus-2 viral load with inactivated PCV-2
US7211379B2 (en) 1997-10-03 2007-05-01 Merial Sas Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2
AU2003248395B2 (en) * 1997-10-03 2006-03-16 Merial Porcine CircoViruses, vaccines and diagnostic reagents
US6391314B1 (en) 1997-10-03 2002-05-21 Merial Porcine circoviruses vaccines diagnostic reagents
UA78180C2 (uk) * 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
FR2772047B1 (fr) * 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
PT1037909E (pt) * 1997-12-11 2007-09-07 Merial Sas Síndrome multi-sistémica do definhamento pós-desmame de porcos
EP1816200B1 (fr) * 1997-12-11 2016-03-09 Merial Virus de syndrome de dépérissement post-sevrage pour cochons
US6287856B1 (en) * 1998-03-13 2001-09-11 University Of Georgia Research Foundation, Inc. Vaccines against circovirus infections
US6943152B1 (en) 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
ES2170622B1 (es) * 1999-12-03 2004-05-16 Consejo Superior De Investigaciones Cientificas Clones y vectores infectivos derivados de coronavirus y sus aplicaciones.
WO2001061024A2 (fr) 2000-02-16 2001-08-23 Large Scale Biology Corporation Vecteurs d'expression de replicon en cercle roulant
JP4038127B2 (ja) 2001-03-27 2008-01-23 ユニバーシティ オブ サスカチュワン サーコウイルスの培養方法
US7276353B2 (en) 2001-12-12 2007-10-02 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7279166B2 (en) 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
DK2281829T3 (da) 2004-12-30 2015-02-23 Boehringer Ingelheim Vetmed PCV2-immunogene sammensætninger til anvendelse i en fremgangsmåde til forebyggelse af PCV2-infektion
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
AU2011253941B2 (en) * 2004-12-30 2015-01-29 Boehringer Ingelheim Animal Health USA Inc. PCV2 immunogenic compositions and methods of producing such compositions
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
ITBO20050123A1 (it) 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
WO2006132598A1 (fr) * 2005-06-07 2006-12-14 Temasek Life Sciences Laboratory Limited Vaccins contre le circovirus porcin de type 2
RU2389506C2 (ru) * 2005-09-09 2010-05-20 Интервет Интернэшнл Б.В. Вакцина против рсv-2
DK2371382T3 (en) 2005-12-29 2016-06-13 Boehringer Ingelheim Vetmedica Inc Use of a PCV2 immunogenic composition to reduce the clinical signs in swine
RU2488407C2 (ru) 2005-12-29 2013-07-27 Берингер Ингельхайм Ветмедика, Инк. Поливалентные иммуногенные композиции pcv2 и способы получения таких композиций
WO2008064299A2 (fr) * 2006-11-22 2008-05-29 Boehringer Ingelheim Vetmedica, Inc. Procédés de réduction des flambées des maladies associées au circovirus porcin
US20100129397A1 (en) * 2006-12-11 2010-05-27 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
BRPI0721083A2 (pt) 2006-12-15 2014-02-25 Boehringer Ingelheim Vetmed Tratamento de porcos com antígeno de pcv2
EP1941903A1 (fr) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxie et traitement du PRDC
EP1958644A1 (fr) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prévention et traitement du PCVD subclinique
AU2007353480B2 (en) * 2007-05-11 2013-09-19 Temasek Life Sciences Laboratory Limited Production of a homogeneous cell line highly permissive to porcine circovirus type 2 (PCV2) infection
US7829274B2 (en) 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
BRPI0821286A8 (pt) * 2007-12-21 2017-08-15 Wyeth Llc Métodos e composições para imunizar porcos contra circovirus suino
AU2008347235A1 (en) * 2007-12-31 2009-07-16 Boehringer Ingelheim Vetmedica, Inc. PCV2 ORF2 virus like particle with foreign amino acid insertion
WO2009126356A2 (fr) * 2008-01-23 2009-10-15 Boehringer Ingelheim Vetmedica, Inc. Compositions immunogènes de mycoplasma hyopneumoniae pcv2, et procédés de production de telles compositions
US20110033495A1 (en) * 2008-02-15 2011-02-10 Boehringer Ingelheim Vetmedica, Inc. Methods and compositions for reducing the impact of enteric diseases
AU2009303845B2 (en) * 2008-10-16 2013-09-12 Zoetis Llc Torque teno virus (TTV) isolates and compositions
US20100150959A1 (en) * 2008-12-15 2010-06-17 Vectogen Pty Ltd. PCV 2-Based Methods and Compositions for the Treatment of Pigs
AR078253A1 (es) 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
MX2012003972A (es) 2009-10-02 2012-05-08 Pionner Hi Bred International Inc Regulacion a la baja de acc sintasa para mejorar el rendimiento de las plantas.
US8846388B2 (en) 2009-10-16 2014-09-30 Zoetis Llc Infectious clones of torque teno virus
AU2010307250B2 (en) * 2009-10-16 2013-09-26 Zoetis Llc Infectious clones of Torque teno virus
JP2013507944A (ja) * 2009-10-22 2013-03-07 ウニヴェルシテート・ライプツィヒ 汎血球減少症罹患仔ウシにおけるサーコウイルス（ｃｉｒｃｏｖｉｒｕｓ）の特定
EP2528931A4 (fr) * 2010-01-25 2013-12-04 Blood Systems Inc Cyclovirus et procédé d'utilisation
KR20110090711A (ko) * 2010-02-04 2011-08-10 녹십자수의약품(주) 신규한 돼지 써코바이러스 타입 2 및 그의 용도
TWI508974B (zh) 2010-12-22 2015-11-21 Sbc Virbac Ltd 豬第二型環狀病毒(Porcine Circovirus Type 2)、含彼之免疫組合物、檢測套組及其應用
BR112013027860A2 (pt) 2011-04-29 2016-11-29 Pioneer Hi Bred Int ácido nucleico isolado, planta ou célula vegetal, método para aumentar a capacidade do dreno, acelerar a remobilização e/ou a senescência e a secagem de grão em uma planta, método para aumentar a tolerância a seca na ausência de uma penalidade de produtividade sob condições sem seca, cassete de expressão e método para reduzir a expressão de zmme293 ou a atividade de zmme293 em uma planta
HUP1100470A2 (en) 2011-08-30 2013-03-28 Mezoegazdasagi Biotechnologiai Kutatokoezpont Nanoparticle-based veterinary vaccine
EP2564869A1 (fr) * 2011-09-02 2013-03-06 Ceva Sante Animale Protéines de capside synthétiques et leurs utilisations
UA113192C2 (xx) 2011-12-06 2016-12-26 Імуногенна композиція проти цирковірусу свиней типу 2 (pcv2)
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
EP2961766B1 (fr) * 2013-03-01 2019-04-10 Boehringer Ingelheim Vetmedica, Inc. Quantification de compositions de vaccin
KR102217387B1 (ko) * 2013-03-11 2021-02-19 주식회사 중앙백신연구소 재조합 효모 전세포(yeast whole cell)을 이용한 돼지 써코바이러스(PCV2) 서브유닛 백신과 그의 제조 방법
EP2789346A1 (fr) 2013-04-11 2014-10-15 CEVA Santé Animale SA Vaccins et polypeptides de fusion
EP2994162B1 (fr) 2013-05-08 2021-04-07 Pharmgate Biologics Inc. Vaccin pour pcv2 et mycoplasme
JP6821429B2 (ja) 2013-09-25 2021-01-27 ゾエティス・サービシーズ・エルエルシー Ｐｃｖ２ｂ分岐ワクチン組成物及び使用方法
US9505808B2 (en) 2013-10-02 2016-11-29 Boehringer Ingelheim Vetmedica, Inc. PCV2 ORF2 protein variant and virus like particles composed thereof
EP3034609A1 (fr) 2014-12-19 2016-06-22 Ceva Sante Animale Virus de recombinaison de la variole porcine et vaccins
EP3254692A1 (fr) 2016-06-10 2017-12-13 Ceva Sante Animale Spv recombiné multivalent
WO2019032830A1 (fr) 2017-08-09 2019-02-14 Dreamwell, Ltd. Structure de support ajustable
EP3720485A1 (fr) 2017-12-08 2020-10-14 Ceva Sante Animale Virus recombiné de la variole porcine et vaccins associés
US20220409715A1 (en) 2018-03-26 2022-12-29 Boehringer Ingelheim Animal Health USA Inc. Method of producing an immunogenic composition
KR20210019030A (ko) 2018-06-11 2021-02-19 세바 상뜨 아니말르 돼지 써코바이러스에 대한 백신 접종
CA3194602A1 (fr) * 2020-10-06 2022-04-14 Abraham Oommen Methode de detection d'arn ou d'adn a partir d'echantillons biologiques
WO2023192936A2 (fr) * 2022-03-30 2023-10-05 Fred Hutchinson Cancer Center Systèmes et procédés pour produire des cellules b qui expriment des anticorps sélectionnés et des produits géniques
CN114736310B (zh) * 2022-06-10 2022-10-28 北京华夏兴洋生物科技有限公司 产生圆环病毒2型病毒样颗粒的蛋白质及生物材料与应用

Family Cites Families (112)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US69750A (en) * 1867-10-15 Henry bean
US69233A (en) * 1867-09-24 Joseph r
FR2422956A1 (fr) 1978-04-13 1979-11-09 Pasteur Institut Procede de detection et de caracterisation d'un acide nucleique ou d'une sequence de celui-ci, et reactif enzymatique pour la mise en oeuvre de ce procede
FR2464269B1 (fr) 1979-08-30 1986-04-18 Anvar Sequence nucleotidique codant l'antigene de surface du virus de l'hepatite b, procede permettant son obtention et antigene obtenu
FR2518755B1 (fr) 1981-12-23 1986-04-11 Pasteur Institut Sonde contenant un acide nucleique modifie et reconnaissable par des anticorps specifiques et utilisation de cette sonde pour detecter et caracteriser une sequence d'adn homologue
US5833975A (en) 1989-03-08 1998-11-10 Virogenetics Corporation Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
US4745051A (en) 1983-05-27 1988-05-17 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
US5545412A (en) 1985-01-07 1996-08-13 Syntex (U.S.A.) Inc. N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor
US4946787A (en) 1985-01-07 1990-08-07 Syntex (U.S.A.) Inc. N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5106733A (en) 1987-06-25 1992-04-21 Immunex Corporation Bovine granulocyte-macrophage colony stimulating factor
SU1538305A1 (ru) 1987-07-21 1994-12-15 Всесоюзный государственный научно-контрольный институт ветеринарных препаратов Госагропрома СССР Ассоциированная вакцина против лептоспироза и парвовирусной инфекции свиней
US5069901A (en) 1988-02-03 1991-12-03 Jones Elaine V Preparation of a recombinant subunit vaccine against pseudorabies infection
EP0454735B1 (fr) 1989-01-23 1996-05-22 Auspharm International Limited Composition de vaccin
US5811103A (en) 1989-03-19 1998-09-22 Akzo Nobel N.V. Hog cholera virus vaccine and diagnostic
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
CA2489769A1 (fr) 1989-03-21 1990-10-04 Philip L. Felgner Expression des sequences polynocleotides exogenes chez un vertebre
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
DE69128361T3 (de) 1990-05-29 2006-04-13 Wyeth Holdings Corp. Impfstoff gegen die pneumonie bei schweinen und verfahren zu seiner herstellung
US5565205A (en) 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
WO1992005255A1 (fr) 1990-09-13 1992-04-02 Commonwealth Scientific And Industrial Research Organisation Genes de cytokine d'origine ovine
GB9023111D0 (en) 1990-10-24 1990-12-05 Wellcome Found Expression system
ES2150419T3 (es) 1990-11-01 2000-12-01 Univ Iowa State Res Found Inc Procedimiento de atenuacion bacteriana y vacuna.
EP0575491B1 (fr) 1991-03-07 2003-08-13 Virogenetics Corporation Souche de vaccin mise au point par genie genetique
ES2026827A6 (es) 1991-03-26 1992-05-01 Ercros Sa Procedimiento para la produccion de una vacuna subunidad contra el parvovirus porcino.
US5580557A (en) 1991-10-09 1996-12-03 Iowa State University Research Foundation, Inc. Live, avirulent salmonella choleraesuis vaccine used for inducing an immune response in animals
US6033904A (en) 1992-01-13 2000-03-07 Syntro Corporation Recombinant swinepox virus
US5382425A (en) 1992-01-13 1995-01-17 Syntro Corporation Recombinant swinepox virus
US5338543A (en) 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US5679356A (en) 1992-07-08 1997-10-21 Schering Corporation Use of GM-CSF as a vaccine adjuvant
JP3149116B2 (ja) * 1992-10-28 2001-03-26 信越化学工業株式会社 ヒトパルボウイルスのエピトープ関連ペプチド
EP0634936B1 (fr) * 1992-11-09 2004-09-01 Zonagen, Inc. Methodes d'immunocontraception
CZ289743B6 (cs) 1993-02-08 2002-03-13 Bayer Corporation Izolát viru vepřového reprodukčního a respiračního syndromu PRRSV, způsob kultivace PRRSV, tkáňová kultura, způsob přípravy vakcíny a vakcína obsahující PRRSV izolát
EP0620277A1 (fr) 1993-03-18 1994-10-19 Merck & Co. Inc. Acides nucléiques comme produits pharmaceutiques
EP0698245A1 (fr) 1993-05-14 1996-02-28 Mds Health Group Limited Fichier electronique pour tests de microbiologie et etablissement de leurs rapports
EP1624068A1 (fr) 1993-06-01 2006-02-08 Life Technologies Inc. Vaccination génétique avec des lipides cationiques
JP3626187B2 (ja) 1993-06-07 2005-03-02 バイカル インコーポレイテッド 遺伝子治療に適するプラスミド
US6015686A (en) 1993-09-15 2000-01-18 Chiron Viagene, Inc. Eukaryotic layered vector initiation systems
FR2711670B1 (fr) 1993-10-22 1996-01-12 Pasteur Institut Vecteur nucléotidique, composition le contenant et vaccin pour l'immunisation à l'encontre d'une hépatite.
GB2285766B (en) 1994-01-21 1997-07-23 Ecc Int Ltd Ceramic casting composition
KR0121105B1 (ko) * 1994-02-04 1997-11-10 문정환 선입선출메모리 버스장치
WO1995024929A2 (fr) 1994-03-15 1995-09-21 Brown University Research Foundation Systeme de liberation de genes polymeres
AU694519B2 (en) 1994-04-29 1998-07-23 Immuno Aktiengesellschaft Recombinant poxviruses with foreign polynucleotides in essential regions
WO1995030437A1 (fr) 1994-05-10 1995-11-16 American Home Products Corporation Vaccin vivant modifie, ameliore, contre le virus respiratoire syncytial bovin (vrsb)
DK53595A (da) 1994-05-13 1995-11-14 Iberica Cyanamid Rekombinante PRRSV-proteiner, diagnostiske kits og vaccine indeholdende sådanne rekombinante PRRSV-proteiner
US5719131A (en) 1994-12-09 1998-02-17 Genzyme Corporation Cationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic molecules
US5840306A (en) * 1995-03-22 1998-11-24 Merck & Co., Inc. DNA encoding human papillomavirus type 18
US6043232A (en) 1997-07-23 2000-03-28 Nitromed, Inc. Nitroso esters of beta-oxo-amides and aryl propionic acid derivatives of non-steroidal antiinflammatory drugs
JPH11504631A (ja) 1995-04-25 1999-04-27 バイカル インコーポレイテッド Ｄｎａ／脂質複合体の単一バイアル製剤
US5681658A (en) * 1995-05-30 1997-10-28 Aluminum Company Of America Gelation-resistant alumina
US5885823A (en) 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
CN1194001A (zh) 1995-06-07 1998-09-23 埃斯库拉普公司 鸡贫血症病毒的中和构象表位
US5820869A (en) 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
US6019980A (en) 1995-06-07 2000-02-01 Connaught Laboratories Limited Nucleic acid respiratory syncytial virus vaccines
US5705385A (en) 1995-06-07 1998-01-06 Inex Pharmaceuticals Corporation Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
US5795872A (en) 1995-09-19 1998-08-18 Pharmadigm, Inc. DNA construct for immunization
FR2751224B1 (fr) 1996-07-19 1998-11-20 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
DE69704011T2 (de) 1996-10-09 2001-06-07 Akzo Nobel Nv Europäische Vakzinstämme des Fortplanzungs-Atmungs-Syndromsvirus des Sweins (PRRSV)
WO1998040499A1 (fr) 1997-03-10 1998-09-17 Heather Lynn Davis Apport de genes dans l'epithelium muqueux a des fins therapeutiques ou d'immunisation
US6004777A (en) 1997-03-12 1999-12-21 Virogenetics Corporation Vectors having enhanced expression, and methods of making and uses thereof
US5990091A (en) 1997-03-12 1999-11-23 Virogenetics Corporation Vectors having enhanced expression, and methods of making and uses thereof
US20030215445A1 (en) * 1997-05-23 2003-11-20 Ginette Serrero Methods and compositions for inhibiting the growth of hematopoietic malignant cells
US6143334A (en) * 1997-10-03 2000-11-07 Sargento Foods Inc. Pasta filata method for manufacturing Swiss-type cheeses
US7211379B2 (en) 1997-10-03 2007-05-01 Merial Sas Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2
US7192594B2 (en) * 1997-10-03 2007-03-20 Merial Limited Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
US6391314B1 (en) * 1997-10-03 2002-05-21 Merial Porcine circoviruses vaccines diagnostic reagents
FR2769322B1 (fr) 1997-10-03 2002-03-08 Merial Sas Nouveaux circovirus porcins, vaccins et reactifs de diagnostic
FR2769321B1 (fr) 1997-10-03 2001-10-26 Merial Sas Nouveaux circovirus porcins, vaccins et reactifs de diagnostics
US6517843B1 (en) * 1999-08-31 2003-02-11 Merial Reduction of porcine circovirus-2 viral load with inactivated PCV-2
FR2781159B1 (fr) 1998-07-06 2000-10-06 Merial Sas Vaccin circovirus et parvovirus porcin
UA78180C2 (uk) * 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
US6165493A (en) 1997-10-22 2000-12-26 New York Blood Center, Inc. "Methods and compositions for decreasing the frequency of HIV, herpesvirus and sexually transmitted bacterial infections"
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US20040062775A1 (en) 1997-12-05 2004-04-01 Agence Francaise De Securite Sanitaire Des Aliments Circovirus sequences associated with piglet weight loss disease (PWD)
PT1037909E (pt) * 1997-12-11 2007-09-07 Merial Sas Síndrome multi-sistémica do definhamento pós-desmame de porcos
US6287856B1 (en) * 1998-03-13 2001-09-11 University Of Georgia Research Foundation, Inc. Vaccines against circovirus infections
US6294176B1 (en) 1998-07-10 2001-09-25 Schering-Plough Veterinary Corp. Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species
AU1131200A (en) 1998-10-23 2000-05-15 Heska Corporation Cationic lipid-mediated enhancement of nucleic acid immunization of cats
US6143333A (en) 1998-11-13 2000-11-07 Purina Mills, Inc. Method of preparing a packaged fish attractant block
FR2789695B1 (fr) 1999-02-11 2003-03-07 Merial Sas Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs
US6943152B1 (en) 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
US6497883B1 (en) 1999-06-10 2002-12-24 Merial Porcine circovirus recombinant poxvirus vaccine
US6139179A (en) 1999-09-03 2000-10-31 Davis-Standard Corporation Extruder screw having multi-channeled barrier section
US6179461B1 (en) 1999-09-03 2001-01-30 Davis-Standard Corporation Extruder screw
GB9921147D0 (en) 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
GB9921146D0 (en) 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
WO2001017556A1 (fr) 1999-09-07 2001-03-15 Shionogi & Co., Ltd. Préparations vaccinales administrables par les muqueuses
WO2001034609A1 (fr) * 1999-11-10 2001-05-17 Optische Werke G. Rodenstock Derives indenochromes heterocycliquement anneles
US6366601B1 (en) * 1999-11-17 2002-04-02 Motorola, Inc. Variable rate spread spectrum communication method and apparatus
US7233407B1 (en) * 2000-02-02 2007-06-19 Xerox Corporation Document production system for capturing web page content
JP3363419B2 (ja) * 1999-12-24 2003-01-08 住友ゴム工業株式会社 重荷重用ラジアルタイヤ
MXPA02012352A (es) 2000-06-15 2004-09-06 Purdue Research Foundation Vacuna para temblores congenitos en cerdos.
JP4768106B2 (ja) 2000-07-31 2011-09-07 スリーエム イノベイティブ プロパティズ カンパニー 接着剤組成物及び熱剥離容易な接着構造
DE10044648A1 (de) * 2000-09-08 2002-03-21 Aventis Behring Gmbh Verfahren zur Vermehrung oder zur Entfernung von Cirocoviren aus biologischem Material
DE10044646A1 (de) 2000-09-08 2002-04-04 Horsch Maschinen Gmbh Spritzgestängeführung
DE10051562A1 (de) * 2000-10-18 2002-04-25 Emitec Emissionstechnologie Beheizbarer Wabenkörper mit zwei verschiedenen Beschichtungen
US6572081B2 (en) * 2000-12-27 2003-06-03 Nkf Kabel B.V. Installation of guide tubes in a protective duct
JP4038127B2 (ja) * 2001-03-27 2008-01-23 ユニバーシティ オブ サスカチュワン サーコウイルスの培養方法
AUPR567401A0 (en) 2001-06-14 2001-07-12 University Of Melbourne, The Circovirus vaccines
US7279166B2 (en) 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7276353B2 (en) 2001-12-12 2007-10-02 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US20030215455A1 (en) 2002-05-14 2003-11-20 Bailey Reynolds Vaccine stabilizer and method of use
CA2507520C (fr) * 2002-11-28 2007-01-23 Research In Motion Limited Antennes a bandes multiples avec structures de connexion et a fentes rayonnantes
US7288529B2 (en) * 2003-04-24 2007-10-30 New York University ALK protein tyrosine kinase, cells and methods embodying and using same
CA2533559C (fr) 2003-07-25 2013-07-02 Boehringer Ingelheim Vetmedica, Inc. Lawsonia intracellularis d'origine europeenne, vaccins, agents diagnostiques et procedes d'utilisation de ceux-ci
US20050279889A1 (en) 2004-06-08 2005-12-22 Safe Flight Instrument Corporation Variable wing spacecraft
US7833707B2 (en) * 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
WO2006074986A2 (fr) 2005-01-13 2006-07-20 Boehringer Ingelheim Vetmedica Gmbh Vaccins ameliores contre le srrp
MX2007012786A (es) 2005-04-13 2008-01-11 Merial Ltd Ensayo para produccion de circovirus porcino.
DK2371382T3 (en) 2005-12-29 2016-06-13 Boehringer Ingelheim Vetmedica Inc Use of a PCV2 immunogenic composition to reduce the clinical signs in swine
US8377070B2 (en) * 2007-05-17 2013-02-19 Michael T. Gauthier Compressor distractor tool
US8214576B2 (en) 2009-03-03 2012-07-03 Vmware, Inc. Zero copy transport for target based storage virtual appliances

Also Published As

Publication number Publication date
DK2000535T3 (da) 2014-04-22
US7244433B2 (en) 2007-07-17
DK1036180T4 (da) 2012-01-23
US20070253971A1 (en) 2007-11-01
CY2014036I1 (el) 2016-04-13
US7758865B2 (en) 2010-07-20
US20060222663A1 (en) 2006-10-05
US20120005768A1 (en) 2012-01-05
ES2548145T3 (es) 2015-10-14
HK1222415A1 (zh) 2017-06-30
US20100189736A1 (en) 2010-07-29
EP3002331A1 (fr) 2016-04-06
PT2000535E (pt) 2014-05-02
FR2772047B1 (fr) 2004-04-09
US7604808B2 (en) 2009-10-20
US20100189743A1 (en) 2010-07-29
US20100226934A1 (en) 2010-09-09
US20100209453A1 (en) 2010-08-19
US20040161410A1 (en) 2004-08-19
US20100166791A1 (en) 2010-07-01
EP1992696A1 (fr) 2008-11-19
US20100189733A1 (en) 2010-07-29
US20100172924A1 (en) 2010-07-08
ES2456959T3 (es) 2014-04-24
DK1036180T3 (da) 2009-03-09
BE2014C049I2 (en) 2018-07-04
US7740865B2 (en) 2010-06-22
EP1036180A2 (fr) 2000-09-20
NL300686I2 (nl) 2022-03-22
US20040076635A1 (en) 2004-04-22
US6703023B1 (en) 2004-03-09
DE69840174D1 (de) 2008-12-11
US7390494B2 (en) 2008-06-24
US7223594B2 (en) 2007-05-29
US7425444B2 (en) 2008-09-16
CY2014036I2 (el) 2016-04-13
EP2330188B1 (fr) 2015-07-15
EP2316925A1 (fr) 2011-05-04
US9700613B2 (en) 2017-07-11
US8415525B2 (en) 2013-04-09
CY1115405T1 (el) 2017-01-04
US20070048780A1 (en) 2007-03-01
PT1036180E (pt) 2009-02-10
US20110033489A1 (en) 2011-02-10
US20120034630A1 (en) 2012-02-09
EP2000535A1 (fr) 2008-12-10
US20040265848A1 (en) 2004-12-30
ES2458309T3 (es) 2014-04-30
HK1158254A1 (en) 2012-07-13
HK1158694A1 (en) 2012-07-20
US20100189732A1 (en) 2010-07-29
NL300686I1 (fr) 2014-08-27
EP2330188A1 (fr) 2011-06-08
EP1036180B2 (fr) 2011-11-02
CY1115424T1 (el) 2016-04-13
FR14C0061I2 (fr) 2016-06-24
EP1036180B1 (fr) 2008-10-29
DK1992696T3 (da) 2014-05-19
HK1126522A1 (en) 2009-09-04
US20070059325A1 (en) 2007-03-15
US20180000927A1 (en) 2018-01-04
US7407803B2 (en) 2008-08-05
ATE412664T1 (de) 2008-11-15
LU92523I2 (fr) 2014-10-20
US7323330B2 (en) 2008-01-29
PT2330188E (pt) 2015-10-23
PT2316925E (pt) 2015-10-23
PT1992696E (pt) 2014-05-27
FR14C0062I1 (fr) 2014-10-10
US8124723B2 (en) 2012-02-28
FR14C0061I1 (fr) 2014-10-10
US7405075B2 (en) 2008-07-29
WO1999029871A3 (fr) 1999-08-19
EP1992696B1 (fr) 2014-02-19
US20070059324A1 (en) 2007-03-15
US20050084497A1 (en) 2005-04-21
FR2772047A1 (fr) 1999-06-11
US10052375B2 (en) 2018-08-21
NL300685I2 (nl) 2022-03-22
US20100221276A1 (en) 2010-09-02
US7148015B2 (en) 2006-12-12
LU92524I2 (fr) 2014-10-20
ES2317679T5 (es) 2012-02-24
AU1491699A (en) 1999-06-28
NL300685I1 (fr) 2014-08-27
US20040091502A1 (en) 2004-05-13
US9717784B2 (en) 2017-08-01
ES2548146T3 (es) 2015-10-14
ES2317679T3 (es) 2009-04-16
US20080233147A1 (en) 2008-09-25
US20070065925A1 (en) 2007-03-22
US20150182616A1 (en) 2015-07-02
US20100074919A1 (en) 2010-03-25
US7741026B2 (en) 2010-06-22
US20090162918A1 (en) 2009-06-25
WO1999029871A2 (fr) 1999-06-17
US20070041990A1 (en) 2007-02-22
US20100215690A1 (en) 2010-08-26
US8715690B2 (en) 2014-05-06
US7179472B2 (en) 2007-02-20
US7722883B2 (en) 2010-05-25
US7297537B2 (en) 2007-11-20
US20050008651A1 (en) 2005-01-13
DK2330188T3 (da) 2015-10-19
US7740866B2 (en) 2010-06-22
CY1116837T1 (el) 2017-03-15
CY2014035I1 (el) 2016-04-13
US20060083756A1 (en) 2006-04-20
EP2000535B1 (fr) 2014-01-22
US20110135677A1 (en) 2011-06-09
US20100189734A1 (en) 2010-07-29
US20150175668A1 (en) 2015-06-25
US20100203072A1 (en) 2010-08-12
CY2014035I2 (el) 2016-04-13
DK2316925T3 (da) 2015-10-12
HK1125676A1 (en) 2009-08-14
US20100189735A1 (en) 2010-07-29
US7951907B2 (en) 2011-05-31
EP2316925B1 (fr) 2015-07-08
US20090092627A1 (en) 2009-04-09
US7261898B2 (en) 2007-08-28
US20100221283A1 (en) 2010-09-02
US8916353B2 (en) 2014-12-23
CY1116761T1 (el) 2017-03-15
FR14C0062I2 (fr) 2016-06-24
US20070110767A1 (en) 2007-05-17
US20090123490A1 (en) 2009-05-14
US20070041989A1 (en) 2007-02-22

Similar Documents

Publication Publication Date Title
BE2014C050I2 (en) Circovirus sequences associated with piglet weight loss disease (PWD)
DE69526973T3 (de) Sequenzen von hepatitis-c-virus genotype 7, und deren verwendung als vorbeugende, therapeutische und diagnostische mittel
Ridpath et al. Segregation of bovine viral diarrhea virus into genotypes
DE69033425T3 (de) HCV-Isolat J-1
WO1998050554A3 (fr) POLYNUCLEOTIDES ET POLYPEPTIDES D'$i(ENTEROCOCCUS FAECALIS)
EP1167542A3 (fr) Sonde pour diagnostiquer des maladies infectieuses liées à Enterococcus Faecalis
CA2005291A1 (fr) Instruments de diagnostic du virus de la peritonite infectieuse des felins
CA2108466A1 (fr) Sequences genomiques du vhc pour le diagnostic et la therapie
ATE366314T1 (de) Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays
EP1197568A3 (fr) Détection et typage du virus de l'hépatite C à l'aide de séquences d'acides nucléiques 5'UTR et NS5
RU93058449A (ru) Hcv геномные последовательности для диагностических и терапевтических целей
ATE338821T1 (de) Strukturprotein von aav, seine herstellung und verwendung
ATE420190T1 (de) Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen
CA2045323A1 (fr) Adn-c du genome du virus de l'hepatite non-a, non-b et polypeptide antigenique
CA2215328A1 (fr) Nouvelles sequences d'adn du cytomegalovirus humain
Odemuyiwa et al. An outbreak of African swine fever in Nigeria: virus isolation and molecular characterization of the VP72 gene of a first isolate from West Africa
Banks DNA restriction fragment length polymorphism among British isolates of Aujeszky's disease virus: use of the polymerase chain reaction to discriminate among strains
EP0297378A3 (fr) 2,5-Dihydropyrroles
WO1999058639A3 (fr) Proteines de structure du virus de la maladie affectant le pancreas des poissons et utilisations de ces dernieres
CA2226457A1 (fr) Oligonucleotides specifiques contre le papillomavirus humain
AU4136797A (en) Novel semaphorin gene: semaphorin y
WO1999004029A3 (fr) Virus de l'hepatite e du porc et ses utilisations
CA2066998A1 (fr) Virus de la varicella-zona recombinant et procede de construction
WO2000028039A3 (fr) Identification de genotypes senv
ATE124991T1 (de) Humaner papillomvirus typ 57, seine dna und die davon kodierten proteine.